VERNALIS
One of the UK’s leading development stage pharmaceutical companies, Vernalis takes promising product candidates along a commercially-focused path to market. They derive pipeline candidates both from successful collaborations with a number of global pharmaceutical businesses and our own research activities. Their pipeline reflects our strategy and is split between our later stage commercial pipeline and our NCE portfolio
VERNALIS
Industry:
Biotechnology Pharmaceutical
Founded:
1988-01-01
Address:
Winnersh, Wokingham, United Kingdom
Country:
United Kingdom
Website Url:
http://www.vernalis.com
Total Employee:
51+
Status:
Active
Contact:
+44 118 977 3133
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Google Maps LetsEncrypt
Similar Organizations
Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.
Corino Therapeutics
Corino Therapeutics is a private, development-stage biopharmaceutical company
PharmaIN
PharmaIN is a development stage biopharmaceutical company,
Current Employees Featured
Scott Harward Vice President, US Marketing and Sales @ Vernalis
Vice President, US Marketing and Sales
Ian R. Garland Chief Executive Officer @ Vernalis
Chief Executive Officer
2009-01-01
David Mackney CFO @ Vernalis
CFO
Sandford Sommer COO @ Vernalis
COO
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2005-11-17 | Cita NeuroPharmaceuticals Inc. | Cita NeuroPharmaceuticals Inc. acquired by Vernalis | 64.5 M USD |
| 2005-07-06 | Ionix Pharmaceuticals | Ionix Pharmaceuticals acquired by Vernalis | 12.5 M GBP |
| 2005-04-03 | Pintex Pharmaceuticals | Pintex Pharmaceuticals acquired by Vernalis | N/A |
Investors List
Thuja Capital
Thuja Capital investment in Venture Round - Vernalis
Official Site Inspections
http://www.vernalis.com Semrush global rank: 12.61 M Semrush visits lastest month: 97
- Host name: 167.71.142.205
- IP address: 167.71.142.205
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Vernalis"
Vernalis
Vernalis collaborates with a wide range of organisations to enable drug discovery programs through both short- and long-term projects.See details»
About us - Vernalis
For more than 25 years Vernalis has been working with our collaborators to tackle some of the most challenging therapeutic targets. From protein-protein interactions to novel targets classes, we have developed a deep expertise in …See details»
Vernalis - Crunchbase Company Profile & Funding
One of the UK’s leading development stage pharmaceutical companies, Vernalis takes promising product candidates along a commercially-focused path to market. They derive pipeline …See details»
Careers - Vernalis
At Vernalis you will be part of one team working in a friendly and collaborative office based on Granta park just 8 miles from Cambridge. As well as free parking on the park, there is a …See details»
Vernalis plc - Wikipedia
Vernalis plc was a UK-based pharmaceuticals business headquartered in Winnersh, with research in Cambridge, and with a Berwyn, PA, US-based commercial operation, Vernalis Therapeutics …See details»
Vernalis Company Profile 2024: Valuation, Investors, Acquisition ...
Vernalis was founded in 1986. Where is Vernalis headquartered? Vernalis is headquartered in Cambridge, United Kingdom. What is the size of Vernalis? Vernalis has 113 total employees. …See details»
Vernalis Research - Wikipedia
Vernalis Research develops and applies fragment and structure-based methods to drug discovery, [1] [2] [3] and has generated cell active lead compounds and development …See details»
Vernalis Company Profile - Office Locations, Competitors ... - Craft
Vernalis is a commercial stage pharmaceutical company, engaging in the research, development and commercialization of pharmaceutical products for various medical disorders.See details»
Vernalis - LinkedIn
Vernalis Research | Fragment & Structure-Based Drug Discovery https://www.vernalis.comSee details»
Our History - Vernalis
The new three-year research collaboration combined Vernalis’ strengths in structure and biophysics-based methods with oncology expertise at Servier, to enable drug discovery …See details»
Vernalis - Products, Competitors, Financials, Employees, …
Vernalis, formerly known as RiboTargets, is a research and development based bio-pharmaceutical company. The firm has one marketed product, frovatriptan, six product …See details»
Vernalis - Crunchbase Company Profile & Funding
In the 15 years that Vernalis has been addressing the most critical challenges of their clients, one thing remains obvious; each business is unique, presenting individualized challenges that …See details»
Vernalis Capital
Vernalis operated in New York, London, Melbourne along with three development centers in India and provided technology solutions to global clients across domains such as tax accounting, …See details»
Vernalis plc - VentureRadar
Vernalis is a world-leading fragment and structure-based biotech company based in Cambridge, UK. By combining structural, thermodynamic and kinetic information from the wide range of …See details»
Leadership Team - Vernalis
For further information about partnering with Vernalis, or to find out more about our capabilities or career opportunities.See details»
Milestone in the oncology drug discovery collaboration with Vernalis
10 June 2021 – Vernalis and Servier are pleased to announce the achievement of one research and one pre-clinical milestone in their oncology drug discovery collaboration, triggering …See details»
Vernalis, a fully owned subsidiary of HitGen Inc., and Servier …
Chengdu, China, 10 June 2021 – Vernalis, a fully owned subsidiary of HitGen Inc., and Servier are pleased to announce the achievement of one research and one pre-clinical milestone in …See details»
Vernalis Capital Investments, Portfolio & Acquisitions | Messari
Jan 2, 2022 · Vernalis Capital is a family-owned investment company that provides strategic leverage to entrepreneurs and aims to build an ecosystem of synergistic companies. They …See details»
News & Publications - Vernalis
For further information about partnering with Vernalis, or to find out more about our capabilities or career opportunities.See details»
Chemistry - vernalis.com
Andrew Potter joined what became Vernalis in 1998 after PhD and post-doctoral work at the Universities of Liverpool and Nottingham. As a medicinal chemist, he has a wide range of …See details»